Tata Tea JaagoRe’s AI campaign champions the power of collective actions for a positive climate impact
The initiative measures the positive impact of daily 'green' actions by individuals…
Cango Inc. Gains Positive Outlook with Initiation of Coverage by Apollo Insights
SHANGHAI, April 29, 2025 /PRNewswire/ -- Cango Inc. (NYSE: CANG) ("Cango" or…
Protara Therapeutics Announces Positive Interim Results Demonstrating Durable Responses in the Ongoing Phase 2 ADVANCED-2 Trial of TARA-002 in Patients with NMIBC
April 26, 2025 10:00 ET | Source: Protara Therapeutics TARA-002 demonstrates 100%…
Pharming receives positive recommendation from NICE for Joenja(leniolisib) as a treatment for APDS
For media and investors only Joenja® is the first and only medicine…
Anavex Life Sciences Announces Positive up to 4-Years Oral Blarcamesine Results from Phase IIb/III Open-Label Extension Trial in Early Alzheimers Disease
ATTENTION-AD trial data through 192 weeks presented at AD/PDTM 2025 Conference Prespecified…
Mohamed Salah and adidas Lead the Charge for Positive Sideline Support, Empowering Young Athletes to Believe You Got This
adidas has revealed the positive behaviours that athletes need from coaches, parents,…
Treace Announces Clinical Study Data Demonstrating Positive Lapiplasty and Adductoplasty Outcomes at the 2025 ACFAS Annual Scientific Conference
PONTE VEDRA, Fla., March 28, 2025 (GLOBE NEWSWIRE) -- Treace Medical Concepts,…
Pleco Therapeutics Announces Positive Outcome of Pre-IND meeting with FDA for PTX-252 in Acute Myeloid Leukaemia
NIJMEGEN, The Netherlands, March 26, 2025 (GLOBE NEWSWIRE) -- Pleco Therapeutics, a…
Capricor Therapeutics Announces Positive Data Demonstrating Long-Term Efficacy of Deramiocel for the Treatment of Duchenne Muscular Dystrophy
March 17, 2025 09:25 ET | Source: Capricor Therapeutics --Preservation of Skeletal…
Mineralys Therapeutics Announces Positive Topline Results from Launch-HTN and Advance-HTN Pivotal Trials of Lorundrostat for the Treatment of Uncontrolled or Resistant Hypertension
– Launch-HTN met its primary endpoint with lorundrostat 50 mg dose achieving…